Onno van de Stolpe

From Wikipedia, the free encyclopedia

Jump to: navigation, search

Onno van de Stolpe (born 25 October 1959, Geldrop [1]) is a Dutch businessman and is currently the CEO of Galapagos, a drug discovery and development company.

[edit] Education

He obtained an MSc degree from the Agricultural University in Wageningen (the Netherlands).

[edit] Career

Mr. Van de Stolpe founded Galapagos NV in 1999 while he was Managing Director Genomics at Introgene (now Crucell). Prior to joining Introgene in 1998, he was Managing Director of Molecular Probes Europe. He established this European headquarters after joining Molecular Probes in the US. Previously, he worked for the Netherlands Foreign Investment Agency in California, where he was responsible for recruiting biotech and medical device companies to locate in the Netherlands. Mr. Van de Stolpe started his career as Manager Business Development at MOGEN in Leiden.

[edit] Sources

De Nederlandse durfal van Galapagos (Dutch)
Galapagos sluit overeenkomst met Eli Lilly (Dutch)

This business-related Dutch biographical article is a stub. You can help Wikipedia by expanding it.

Persondata
Name	Stolpe, Onno Van De
Alternative names
Short description
Date of birth	1959
Place of birth
Date of death
Place of death

Onno van de Stolpe

[edit] Education

[edit] Career

[edit] Sources

Personal tools

Namespaces

Variants

Views

Actions

Search

Navigation

Interaction

Toolbox

Print/export